Future Directions with DNA Repair Inhibitors

A Roadmap for Disruptive Approaches to Cancer Therapy

Research output: Chapter in Book/Report/Conference proceedingChapter

11 Citations (Scopus)

Abstract

This chapter helps learn the intricacies of efficient, accurate DNA damage response and repair enables researchers to create new anticancer agents that capitalize on cancer-specific alterations to those repair mechanisms, which are often early events in tumorigenic transformation. Many intrinsic and extrinsic factors threaten genome stability; and, when it is disrupted, a path of uncontrolled growth and cancer begins. Disruptions in DNA repair pathways predispose cells to accumulating damage, and subsequently, mutations. However, both mutations and heterozygous polymorphisms can alter DNA damage response and repair processes. Abundant evidence exists that, as cancers progress, they become increasingly more malignant by accumulating more mutations in their DNA repair proteins, which may limit or extinguish the functionality of a repair pathway or other key element of DNA maintenance.

Original languageEnglish
Title of host publicationDNA Repair in Cancer Therapy
PublisherElsevier Inc.
Pages301-310
Number of pages10
ISBN (Print)9780123849991
DOIs
StatePublished - 2012

Fingerprint

DNA Repair
Mutation
DNA Damage
Neoplasms
Neoplastic Cell Transformation
Intrinsic Factor
Genomic Instability
Therapeutics
Antineoplastic Agents
Maintenance
Research Personnel
Direction compound
DNA
Growth
Proteins

ASJC Scopus subject areas

  • Dentistry(all)
  • Medicine(all)

Cite this

Future Directions with DNA Repair Inhibitors : A Roadmap for Disruptive Approaches to Cancer Therapy. / Kelley, Mark.

DNA Repair in Cancer Therapy. Elsevier Inc., 2012. p. 301-310.

Research output: Chapter in Book/Report/Conference proceedingChapter

@inbook{1e601004b0f4447886e75cf75358de6c,
title = "Future Directions with DNA Repair Inhibitors: A Roadmap for Disruptive Approaches to Cancer Therapy",
abstract = "This chapter helps learn the intricacies of efficient, accurate DNA damage response and repair enables researchers to create new anticancer agents that capitalize on cancer-specific alterations to those repair mechanisms, which are often early events in tumorigenic transformation. Many intrinsic and extrinsic factors threaten genome stability; and, when it is disrupted, a path of uncontrolled growth and cancer begins. Disruptions in DNA repair pathways predispose cells to accumulating damage, and subsequently, mutations. However, both mutations and heterozygous polymorphisms can alter DNA damage response and repair processes. Abundant evidence exists that, as cancers progress, they become increasingly more malignant by accumulating more mutations in their DNA repair proteins, which may limit or extinguish the functionality of a repair pathway or other key element of DNA maintenance.",
author = "Mark Kelley",
year = "2012",
doi = "10.1016/B978-0-12-384999-1.10014-9",
language = "English",
isbn = "9780123849991",
pages = "301--310",
booktitle = "DNA Repair in Cancer Therapy",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Future Directions with DNA Repair Inhibitors

T2 - A Roadmap for Disruptive Approaches to Cancer Therapy

AU - Kelley, Mark

PY - 2012

Y1 - 2012

N2 - This chapter helps learn the intricacies of efficient, accurate DNA damage response and repair enables researchers to create new anticancer agents that capitalize on cancer-specific alterations to those repair mechanisms, which are often early events in tumorigenic transformation. Many intrinsic and extrinsic factors threaten genome stability; and, when it is disrupted, a path of uncontrolled growth and cancer begins. Disruptions in DNA repair pathways predispose cells to accumulating damage, and subsequently, mutations. However, both mutations and heterozygous polymorphisms can alter DNA damage response and repair processes. Abundant evidence exists that, as cancers progress, they become increasingly more malignant by accumulating more mutations in their DNA repair proteins, which may limit or extinguish the functionality of a repair pathway or other key element of DNA maintenance.

AB - This chapter helps learn the intricacies of efficient, accurate DNA damage response and repair enables researchers to create new anticancer agents that capitalize on cancer-specific alterations to those repair mechanisms, which are often early events in tumorigenic transformation. Many intrinsic and extrinsic factors threaten genome stability; and, when it is disrupted, a path of uncontrolled growth and cancer begins. Disruptions in DNA repair pathways predispose cells to accumulating damage, and subsequently, mutations. However, both mutations and heterozygous polymorphisms can alter DNA damage response and repair processes. Abundant evidence exists that, as cancers progress, they become increasingly more malignant by accumulating more mutations in their DNA repair proteins, which may limit or extinguish the functionality of a repair pathway or other key element of DNA maintenance.

UR - http://www.scopus.com/inward/record.url?scp=80054761771&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80054761771&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-384999-1.10014-9

DO - 10.1016/B978-0-12-384999-1.10014-9

M3 - Chapter

SN - 9780123849991

SP - 301

EP - 310

BT - DNA Repair in Cancer Therapy

PB - Elsevier Inc.

ER -